Variant report

Variant	nsv1046308
Chromosome Location	chr10:96441300-96633012
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr10:96447569-96447764	HepG2	liver:	n/a	n/a
2	CEBPB	chr10:96581486-96581791	A549	lung:	n/a	chr10:96581633-96581644
3	CEBPB	chr10:96543674-96543868	A549	lung:	n/a	chr10:96543736-96543747
4	CEBPB	chr10:96610925-96611288	HepG2	liver:	n/a	chr10:96611099-96611110
5	CEBPB	chr10:96487899-96488178	A549	lung:	n/a	chr10:96488055-96488066
6	CEBPB	chr10:96543674-96543836	HepG2	liver:	n/a	chr10:96543736-96543747
7	CEBPB	chr10:96487903-96488237	HepG2	liver:	n/a	chr10:96488055-96488066
8	CEBPB	chr10:96504015-96504089	HepG2	liver:	n/a	chr10:96504062-96504073
9	CEBPB	chr10:96520862-96521099	HepG2	liver:	n/a	chr10:96520959-96520970 chr10:96520961-96520970 chr10:96520960-96520971 chr10:96520961-96520970 chr10:96520961-96520970 chr10:96520961-96520970
10	CEBPB	chr10:96520913-96521049	A549	lung:	n/a	chr10:96520959-96520970 chr10:96520961-96520970 chr10:96520960-96520971 chr10:96520961-96520970 chr10:96520961-96520970 chr10:96520961-96520970
11	CEBPB	chr10:96485737-96485940	A549	lung:	n/a	n/a
12	CEBPB	chr10:96581454-96581783	HepG2	liver:	n/a	chr10:96581633-96581644
13	CEBPB	chr10:96487954-96488117	H1-hESC	embryonic stem cell:	n/a	chr10:96488055-96488066
14	CEBPB	chr10:96610998-96611149	K562	blood:	n/a	chr10:96611099-96611110
15	CEBPB	chr10:96485885-96485913	K562	blood:	n/a	n/a
16	CEBPB	chr10:96520891-96521011	IMR90	lung:	n/a	chr10:96520959-96520970 chr10:96520961-96520970 chr10:96520960-96520971 chr10:96520961-96520970 chr10:96520961-96520970 chr10:96520961-96520970
17	CEBPB	chr10:96453074-96453300	K562	blood:	n/a	chr10:96453142-96453153
18	CEBPB	chr10:96487896-96488218	IMR90	lung:	n/a	chr10:96488055-96488066
19	CEBPB	chr10:96507808-96507867	A549	lung:	n/a	n/a
20	CEBPB	chr10:96452997-96453294	HepG2	liver:	n/a	chr10:96453142-96453153
21	CEBPB	chr10:96610935-96611206	A549	lung:	n/a	chr10:96611099-96611110
22	CEBPB	chr10:96485747-96485947	IMR90	lung:	n/a	n/a
23	CEBPB	chr10:96610933-96611257	IMR90	lung:	n/a	chr10:96611099-96611110
24	CTCF	chr10:96562980-96563130	RPTEC	kidney:	n/a	n/a
25	CTCF	chr10:96626963-96627063	LNCaP	prostate:	n/a	n/a
26	CTCF	chr10:96441160-96441310	Caco-2	colon:	n/a	n/a
27	CTCF	chr10:96563080-96563230	RPTEC	kidney:	n/a	n/a
28	CTCF	chr10:96512231-96512340	MCF-7	breast:	n/a	n/a
29	CTCF	chr10:96516926-96516994	Medullo	brain:	n/a	n/a
30	CTCF	chr10:96530820-96530970	HEK293	kidney:	n/a	n/a
31	CTCF	chr10:96618977-96619055	MCF-7	breast:	n/a	n/a
32	CTCF	chr10:96563100-96563250	MCF-7	breast:	n/a	n/a
33	CTCF	chr10:96621754-96621802	LNCaP	prostate:	n/a	n/a
34	CTCF	chr10:96505096-96505149	Kidney_OC	kidney:	n/a	n/a
35	CTCF	chr10:96530910-96530967	H1-hESC	embryonic stem cell:	n/a	n/a
36	CTCF	chr10:96446280-96446430	Caco-2	colon:	n/a	n/a
37	CTCF	chr10:96563126-96563151	HepG2	liver:	n/a	n/a
38	CTCF	chr10:96570817-96570874	GM13976	blood:	n/a	n/a
39	CTCF	chr10:96512257-96512384	MCF-7	breast:	n/a	n/a
40	CTCF	chr10:96552160-96552310	Hela-S3	cervix:	n/a	n/a
41	CTCF	chr10:96517820-96517970	HepG2	liver:	n/a	n/a
42	CTCF	chr10:96596395-96596418	LNCaP	prostate:	n/a	n/a
43	CTCF	chr10:96441406-96441477	Lung_OC	lung:	n/a	n/a
44	CTCF	chr10:96534991-96535093	GM20000	blood:	n/a	n/a
45	CTCF	chr10:96577722-96577829	Kidney_OC	kidney:	n/a	n/a
46	E2F4	chr10:96511121-96511131	MCF10A-Er-Src	breast:	n/a	n/a
47	FOS	chr10:96485613-96486005	MCF10A-Er-Src	breast:	n/a	n/a
48	FOS	chr10:96485608-96485959	MCF10A-Er-Src	breast:	n/a	n/a
49	FOS	chr10:96485600-96485967	MCF10A-Er-Src	breast:	n/a	n/a
50	FOS	chr10:96545059-96545259	MCF10A-Er-Src	breast:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr10:96442674-96442724	GM12878	blood:	n/a
2	chr10:96522433-96522483	NB4	blood:	n/a
3	chr10:96442674-96442724	GM12878	blood:	n/a
4	chr10:96522433-96522483	NB4	blood:	n/a
5	chr10:96521152-96521202	AG10803	skin:	n/a
6	chr10:96443165-96443215	HRPEpiC	eye:	n/a
7	chr10:96521086-96521136	PFSK-1	brain:	n/a
8	chr10:96521152-96521202	Jurkat	blood:	n/a
9	chr10:96447464-96447514	GM12878	blood:	n/a
10	chr10:96446783-96446833	HepG2	liver:	n/a
11	chr10:96521152-96521202	HEEpiC	esophagus:	n/a
12	chr10:96442154-96442204	AG04449	skin:	fetal
13	chr10:96442031-96442081	Hepatocyte	liver:	n/a
14	chr10:96523248-96523298	HRCEpiC	kidney:	n/a
15	chr10:96442154-96442204	AG09309	skin:	n/a
16	chr10:96443383-96443433	PFSK-1	brain:	n/a
17	chr10:96442154-96442204	CMK	blood:	n/a
18	chr10:96443071-96443121	PrEC	prostate:	n/a
19	chr10:96443383-96443433	NHBE	bronchial:	n/a
20	chr10:96443383-96443433	LNCaP	prostate:	n/a
21	chr10:96442154-96442204	SK-N-MC	brain:	n/a
22	chr10:96443071-96443121	AoSMC	blood vessel:	n/a
23	chr10:96443195-96443245	SK-N-SH_RA	brain:	n/a
24	chr10:96443165-96443215	AoSMC	blood vessel:	n/a
25	chr10:96442031-96442081	HepG2	liver:	n/a
26	chr10:96447464-96447514	A549	lung:	n/a
27	chr10:96442674-96442724	Hela-S3	cervix:	n/a
28	chr10:96447464-96447514	NT2-D1	testis:	n/a
29	chr10:96521086-96521136	HRPEpiC	eye:	n/a
30	chr10:96442154-96442204	NHDF-neo	bronchial:	n/a
31	chr10:96522433-96522483	SKMC	muscle:	n/a
32	chr10:96442031-96442081	BE2_C	brain:	n/a
33	chr10:96523248-96523298	MCF10A-Er-Src	breast:	n/a
34	chr10:96447464-96447514	LNCaP	prostate:	n/a
35	chr10:96523248-96523298	NHBE	bronchial:	n/a
36	chr10:96442674-96442724	RPTEC	kidney:	n/a
37	chr10:96522433-96522483	HRPEpiC	eye:	n/a
38	chr10:96522433-96522483	GM12878	blood:	n/a
39	chr10:96443383-96443433	AG10803	skin:	n/a
40	chr10:96521086-96521136	SK-N-MC	brain:	n/a
41	chr10:96521152-96521202	Hela-S3	cervix:	n/a
42	chr10:96443071-96443121	GM12878	blood:	n/a
43	chr10:96521152-96521202	NHBE	bronchial:	n/a
44	chr10:96523347-96523397	HAEpiC	amniotic membrane:	n/a
45	chr10:96442154-96442204	K562	blood:	n/a
46	chr10:96442154-96442204	HMEC	breast:	n/a
47	chr10:96521152-96521202	HPAEpiC	pulmonary alveolar:	n/a
48	chr10:96521086-96521136	HPAEpiC	pulmonary alveolar:	n/a
49	chr10:96442674-96442724	AG09309	skin:	n/a
50	chr10:96446783-96446833	PFSK-1	brain:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr10:96479612..96481874-chr10:96483604..96486212,2	MCF-7	breast:
2	chr10:96479612..96481874-chr10:96483604..96486212,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CYP2C8-4	chr10:96632715-96632886	NONHSAT015740
2	lnc-CYP2C8-4	chr10:96625946-96626096	NONHSAT015740
3	lnc-CYP2C8-4	chr10:96625609-96625760	NONHSAT015740

Variant related genes	Relation type
CYP2C18	TF binding region
CYP2C58P	TF binding region
CYP2C19	TF binding region
MTND4P19	TF binding region
CYP2C18	CpG island
CYP2C58P	CpG island
CYP2C19	CpG island
MTND4P19	CpG island

Extended variants
information (count: 9179 )
Associated
traits (count: 78 )

Variant overlapped rSNPs/rCNVs (count:9179 , 50 per page) page: 1 2 3 4 5 6 7 ... 184

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs717238	chr10:96441300-96441301	Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs147403219	chr10:96441319-96441320	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs572840101	chr10:96441360-96441361	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs542164848	chr10:96441392-96441393	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs397844695	chr10:96441424-96441425	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs561940423	chr10:96441504-96441505	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs575552861	chr10:96441514-96441515	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs192592307	chr10:96441526-96441527	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs564081332	chr10:96441556-96441557	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs142661740	chr10:96441585-96441586	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs184586182	chr10:96441596-96441597	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs188202788	chr10:96441646-96441647	Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs10736086	chr10:96441650-96441651	Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs528447882	chr10:96441676-96441677	Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs548507659	chr10:96441697-96441698	Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs371150771	chr10:96441729-96441730	Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs111974181	chr10:96441757-96441758	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs556099853	chr10:96441782-96441783	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs551156923	chr10:96441786-96441787	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs570915457	chr10:96441788-96441789	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs575985930	chr10:96441798-96441799	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs539532277	chr10:96441835-96441836	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs553528514	chr10:96441859-96441860	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs542506923	chr10:96441894-96441895	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs535728772	chr10:96441916-96441917	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs17110192	chr10:96441927-96441928	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
27	rs139691479	chr10:96441928-96441929	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs17110194	chr10:96441949-96441950	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
29	rs541237296	chr10:96442031-96442032	Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
30	rs180690039	chr10:96442045-96442046	Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
31	rs557950792	chr10:96442069-96442070	Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
32	rs560536680	chr10:96442081-96442082	Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
33	rs577738403	chr10:96442112-96442113	Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs115834519	chr10:96442154-96442155	Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
35	rs184343113	chr10:96442155-96442156	Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
36	rs56024124	chr10:96442170-96442171	Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs541816340	chr10:96442189-96442190	Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
38	rs561698252	chr10:96442215-96442216	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs76705309	chr10:96442235-96442236	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs57713587	chr10:96442266-96442267	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs115534384	chr10:96442278-96442279	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs533341008	chr10:96442282-96442283	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs189998337	chr10:96442354-96442355	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs116862032	chr10:96442392-96442393	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs149953226	chr10:96442467-96442468	Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs181214526	chr10:96442489-96442490	Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs568835661	chr10:96442539-96442540	Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs576445119	chr10:96442558-96442559	Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs187072977	chr10:96442585-96442586	Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs191458268	chr10:96442588-96442589	Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:78)

Disease	PMID	Source
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
Prostate cancer	18632612	CNVD
Cockayne syndrome	18421352	CNVD
Glioblastoma	16823260	CNVD
Medulloblastoma	16968546	CNVD
Neuroblastoma	17533364	CNVD
Squamous cell cancer	21044232	CNVD
Glioma	21971842	CNVD
Cancer	21637783	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Lung cancer	18438408	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Usher syndrome	20538994	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21785460	CNVD
Acute myeloid leukemia	20729466	CNVD
Prostate cancer	16573809	CNVD
Paraganglioma	17535989	CNVD
Submicroscopic aberration syndrome	21292638	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Pulmonary chondroma	17535989	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Colorectal cancer	18645599	CNVD
Polyposis syndrome	18645599	CNVD
Prostate cancer	17245344	CNVD
Glioblastoma multiforme	17369134	CNVD
Glioblastoma multiforme	21750150	CNVD
Breast cancer	22032731	CNVD
Ovarian cancer	20844748	CNVD
Glioblastoma multiforme	17002787	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21364760	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Wilms tumour	21544195	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Urothelial carcinoma	21177765	CNVD
Breast cancer	16397240	CNVD
Chronic lymphocytic leukemia	21049055	CNVD
Cervical cancer	21062161	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	24453001	CNVD
Breast cancer	16608533	CNVD
Intracranial aneurysm	16715129	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
small cell lung cancer	20016488	CNVD
Schizophrenia	20967226	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	17431168	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Oligozoospermia	20877625	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Schizophrenia	23813976	CNVD

Chromatin state (count:326 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:96435200-96444800	Weak transcription	Gastric	stomach
2	chr10:96436000-96443400	Enhancers	Fetal Intestine Large	intestine
3	chr10:96436400-96442000	Weak transcription	Rectal Mucosa Donor 29	rectum
4	chr10:96439600-96442800	Enhancers	HepG2	liver
5	chr10:96439600-96443200	Enhancers	Rectal Mucosa Donor 31	rectum
6	chr10:96440000-96442000	Weak transcription	Stomach Mucosa	stomach
7	chr10:96440200-96441600	Enhancers	Liver	Liver
8	chr10:96440200-96442200	Weak transcription	Duodenum Mucosa	Duodenum
9	chr10:96440200-96443200	Enhancers	Fetal Intestine Small	intestine
10	chr10:96440800-96442600	Enhancers	A549	lung
11	chr10:96441600-96442000	Flanking Active TSS	Liver	Liver
12	chr10:96441600-96443400	Enhancers	Colonic Mucosa	Colon
13	chr10:96442000-96442200	Active TSS	Liver	Liver
14	chr10:96442000-96443200	Enhancers	Rectal Mucosa Donor 29	rectum
15	chr10:96442000-96443200	Enhancers	Stomach Mucosa	stomach
16	chr10:96442200-96442400	Flanking Active TSS	Liver	Liver
17	chr10:96442200-96443000	Enhancers	Duodenum Mucosa	Duodenum
18	chr10:96442200-96443200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
19	chr10:96442400-96442600	Enhancers	HUES48 Cell Line	embryonic stem cell
20	chr10:96442400-96442600	Enhancers	iPS-20b Cell Line	embryonic stem cell
21	chr10:96442400-96443000	Enhancers	Adipose Nuclei	Adipose
22	chr10:96442400-96447000	Active TSS	Liver	Liver
23	chr10:96442800-96443600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
24	chr10:96443000-96443200	Flanking Active TSS	Duodenum Mucosa	Duodenum
25	chr10:96443000-96443400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
26	chr10:96443000-96443400	Enhancers	NHEK	skin
27	chr10:96443000-96443600	Enhancers	HUES64 Cell Line	embryonic stem cell
28	chr10:96443200-96443400	Enhancers	HUES48 Cell Line	embryonic stem cell
29	chr10:96443200-96443400	Enhancers	iPS-20b Cell Line	embryonic stem cell
30	chr10:96443200-96443400	Flanking Active TSS	Fetal Intestine Small	intestine
31	chr10:96443200-96443600	Flanking Active TSS	Rectal Mucosa Donor 31	rectum
32	chr10:96443200-96446800	Active TSS	Duodenum Mucosa	Duodenum
33	chr10:96443200-96447200	Active TSS	Stomach Mucosa	stomach
34	chr10:96443400-96443600	Weak transcription	Colonic Mucosa	Colon
35	chr10:96443400-96445000	Active TSS	Fetal Stomach	stomach
36	chr10:96443400-96445400	Active TSS	Fetal Intestine Large	intestine
37	chr10:96443400-96445600	Active TSS	Fetal Intestine Small	intestine
38	chr10:96443600-96444000	Active TSS	Rectal Mucosa Donor 31	rectum
39	chr10:96443600-96444200	Active TSS	Colonic Mucosa	Colon
40	chr10:96444000-96444200	Active TSS	Esophagus	oesophagus
41	chr10:96444000-96444600	Active TSS	Duodenum Smooth Muscle	Duodenum
42	chr10:96444000-96445600	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
43	chr10:96444600-96444800	Enhancers	Esophagus	oesophagus
44	chr10:96444800-96445000	Flanking Active TSS	Esophagus	oesophagus
45	chr10:96444800-96445200	Active TSS	Gastric	stomach
46	chr10:96445000-96445200	Active TSS	Esophagus	oesophagus
47	chr10:96445200-96449600	Weak transcription	Esophagus	oesophagus
48	chr10:96445200-96449600	Weak transcription	Gastric	stomach
49	chr10:96445400-96445800	ZNF genes & repeats	Fetal Intestine Large	intestine
50	chr10:96445600-96446800	Weak transcription	Fetal Intestine Small	intestine

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links